Circulation, Vol 89, 952-954, Copyright © 1994 by American Heart Association
C Bonithon-Kopp, P Ducimetiere, PJ Touboul, JM Feve, E Billaud, D Courbon and V Heraud
BACKGROUND: Mechanisms underlying the previously reported association
between a deletion polymorphism in the gene encoding for angiotensin-
converting enzyme (ACE) and the risk of myocardial infarction in low- risk
subjects are unclear. The purpose of this case-control study was to examine
the relation of plasma ACE activity to intimal-medial thickness of the
carotid wall measured ultrasonographically in an apparently healthy
population. METHODS AND RESULTS: We determined plasma ACE activity in 80
pairs of subjects without any history of ischemic heart disease or any
treatment of hypertension and diabetes. Cases and control subjects were
defined on the basis of intimal-medial thickness measured in the common
carotid arteries by B-mode ultrasound and were matched for sex,
sonographer, and the presence of atheromatous plaques. Subjects were
selected from a sample of 434 men and 602 women between 60 and 69 years old
participating in an ongoing study on vascular aging (EVA). Subjects with
intimal-medial thickening (cases) showed a slight but not significant
increase in plasma ACE activity in comparison with control subjects (P <
.16). However, after exclusion of subjects receiving lipid-lowering drugs,
the mean plasma ACE activity became significantly higher in cases than in
control subjects (29.9 +/- 7.7 U/L versus 27.5 +/- 8.0 U/L; n = 54 pairs, P
< .03). The mean case- control difference in plasma ACE activity was
further increased when analysis was restricted to pairs without carotid
atheromatous plaques (n = 42 pairs). After adjustment for body mass index,
smoking, and systolic blood pressure, the odds ratio for having carotid
wall thickening based on 1 SD difference in log ACE was 2.29 (95%
confidence interval, 1.16 to 4.52; P < .02). CONCLUSIONS: The results of
the study suggest that chronic exposure to high levels of plasma ACE could
be involved in structural changes of the arterial wall.
ARTICLES
Plasma angiotensin-converting enzyme activity and carotid wall thickening
INSERM U258, Hopital Broussais, Paris, France.
This article has been cited by other articles:
 |
|
 |
|
  J.-P. Baguet, L. Hammer, P. Levy, H. Pierre, S. Launois, J.-M. Mallion, and J.-L. Pepin The Severity of Oxygen Desaturation Is Predictive of Carotid Wall Thickening and Plaque Occurrence Chest, November 1, 2005; 128(5): 3407 - 3412. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hosomi, K. Mizushige, H. Ohyama, T. Takahashi, M. Kitadai, Y. Hatanaka, H. Matsuo, M. Kohno, and J. A. Koziol Angiotensin-Converting Enzyme Inhibition With Enalapril Slows Progressive Intima-Media Thickening of the Common Carotid Artery in Patients With Non-Insulin-Dependent Diabetes Mellitus Stroke, July 1, 2001; 32(7): 1539 - 1545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. P. Rossi, S. Taddei, A. Virdis, L. Ghiadoni, G. Albertin, S. Favilla, I. Sudano, A. C. Pessina, and A. Salvetti Exclusion of the ACE D/I Gene Polymorphism as a Determinant of Endothelial Dysfunction Hypertension, February 1, 2001; 37(2): 293 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Crisan and J. Carr Angiotensin I-Converting Enzyme: Genotype and Disease Associations J. Mol. Diagn., August 1, 2000; 2(3): 105 - 115. [Full Text]
|
|
|
|
 |
|
 W. Koch, A. Kastrati, J. Mehilli, C. Bottiger, N. von Beckerath, and A. Schomig Insertion/Deletion Polymorphism of the Angiotensin I-Converting Enzyme Gene Is Not Associated With Restenosis After Coronary Stent Placement Circulation, July 11, 2000; 102(2): 197 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Guerin, G. M. London, S. J. Marchais, and F. Metivier Arterial stiffening and vascular calcifications in end-stage renal disease Nephrol. Dial. Transplant., July 1, 2000; 15(7): 1014 - 1021. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Topouchian, R. Asmar, F. Sayegh, A. Rudnicki, A. Benetos, A. M. Bacri, and M. E. Safar Changes in Arterial Structure and Function Under Trandolapril-Verapamil Combination in Hypertension Stroke, May 1, 1999; 30(5): 1056 - 1064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. O'Malley, J. P. BS, C. L. Maslen, and D. R. Illingworth Angiotensin-Converting Enzyme DD Genotype and Cardiovascular Disease in Heterozygous Familial Hypercholesterolemia Circulation, May 19, 1998; 97(18): 1780 - 1783. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Blacher, K. Demuth, A. P. Guerin, M. E. Safar, N. Moatti, and G. M. London Influence of Biochemical Alterations on Arterial Stiffness in Patients With End-stage Renal Disease Arterioscler Thromb Vasc Biol, April 1, 1998; 18(4): 535 - 541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Challah, E. Villard, M. Philippe, A. Ribadeau-Dumas, B. Giraudeau, P. Janiak, J.-P. Vilaine, F. Soubrier, and J.-B. Michel Angiotensin I-Converting Enzyme Genotype Influences Arterial Response to Injury in Normotensive Rats Arterioscler Thromb Vasc Biol, February 1, 1998; 18(2): 235 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Watanabe, T. Ishigami, Y. Kawano, T. Umahara, A. Nakamori, S. Mizushima, K. Hibi, I. Kobayashi, K. Tamura, H. Ochiai, et al. Angiotensin-Converting Enzyme Gene I/D Polymorphism and Carotid Plaques in Japanese Hypertension, September 1, 1997; 30(3): 569 - 573. [Abstract] [Full Text]
|
|
|
|
|
|
C. Amant, C. Bauters, J.-C. Bodart, J.-M. Lablanche, G. Grollier, N. Danchin, M. Hamon, F. Richard, N. Helbecque, E. P. McFadden, et al. D Allele of the Angiotensin I–Converting Enzyme Is a Major Risk Factor for Restenosis After Coronary Stenting Circulation, July 1, 1997; 96(1): 56 - 60. [Abstract] [Full Text]
|
|
|
|
|
|
A. Benetos, S. Gautier, S. Ricard, J. Topouchian, R. Asmar, O. Poirier, E. Larosa, L. Guize, M. Safar, F. Soubrier, et al. Influence of Angiotensin-Converting Enzyme and Angiotensin II Type 1 Receptor Gene Polymorphisms on Aortic Stiffness in Normotensive and Hypertensive Patients Circulation, August 15, 1996; 94(4): 698 - 703. [Abstract] [Full Text]
|
|
|
|
|
|
R. F. Badenhop, X. L. Wang, and D. E.L. Wilcken Association Between an Angiotensinogen Microsatellite Marker in Children and Coronary Events in Their Grandparents Circulation, June 15, 1996; 93(12): 2092 - 2096. [Abstract] [Full Text]
|
|
|
|
|
|
R. Duggirala, C. G. Villalpando, D. H. O'Leary, M. P. Stern, and J. Blangero Genetic Basis of Variation in Carotid Artery Wall Thickness Stroke, May 1, 1996; 27(5): 833 - 837. [Abstract] [Full Text]
|
|
|
|
|
|
M. L. Muiesan, G. Pasini, M. Salvetti, S. Calebich, R. Zulli, M. Castellano, D. Rizzoni, G. Bettoni, A. Cinelli, E. Porteri, et al. Cardiac and Vascular Structural Changes : Prevalence and Relation to Ambulatory Blood Pressure in a Middle-aged General Population in Northern Italy: The Vobarno Study Hypertension, May 1, 1996; 27(5): 1046 - 1052. [Abstract] [Full Text]
|
|
|
|
|
|
A. Catto, A. M. Carter, J. H. Barrett, M. Stickland, J. Bamford, J. A. Davies, and P. J. Grant Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Cerebrovascular Disease Stroke, March 1, 1996; 27(3): 435 - 440. [Abstract] [Full Text]
|
|
|
|
|
|
C. Bonithon-Kopp, P.-J. Touboul, C. Berr, C. Leroux, F. Mainard, D. Courbon, and P. Ducimetiere Relation of Intima-Media Thickness to Atherosclerotic Plaques in Carotid Arteries : The Vascular Aging (EVA) Study Arterioscler Thromb Vasc Biol, February 1, 1996; 16(2): 310 - 316. [Abstract] [Full Text]
|
|
|
|
|
|
M. R. Adams, A. Nakagomi, A. Keech, J. Robinson, R. McCredie, B. P. Bailey, S. B. Freedman, and D. S. Celermajer Carotid Intima-Media Thickness Is Only Weakly Correlated With the Extent and Severity of Coronary Artery Disease Circulation, October 15, 1995; 92(8): 2127 - 2134. [Abstract] [Full Text]
|
|
|
|
|
|
G. Rossi, A. Rossi, A. Sacchetto, E. Pavan, and A. C. Pessina Hypertensive Cerebrovascular Disease and the Renin-Angiotensin System Stroke, September 1, 1995; 26(9): 1700 - 1706. [Abstract] [Full Text]
|
|
|
|
|
|
M. J. Roman, T. G. Pickering, R. Pini, J. E. Schwartz, and R. B. Devereux Prevalence and Determinants of Cardiac and Vascular Hypertrophy in Hypertension Hypertension, August 1, 1995; 26(2): 369 - 373. [Abstract] [Full Text]
|
|
|
|
|
|
M. E. Safar and E. D. Frohlich The Arterial System in Hypertension : A Prospective View Hypertension, July 1, 1995; 26(1): 10 - 14. [Abstract] [Full Text]
|
|
|
|
|
|
A. Benetos, J. Topouchian, S. Ricard, S. Gautier, A. Bonnardeaux, R. Asmar, O. Poirier, F. Soubrier, M. Safar, and F. Cambien Influence of Angiotensin II Type 1 Receptor Polymorphism on Aortic Stiffness in Never-Treated Hypertensive Patients Hypertension, July 1, 1995; 26(1): 44 - 47. [Abstract] [Full Text]
|
|
|
|
|
|
A. Kamitani, H. Rakugi, J. Higaki, M. Ohishi, S.-J. Shi, S. Takami, Y. Nakata, Y. Higashino, K. Fujii, H. Mikami, et al. Enhanced Predictability of Myocardial Infarction in Japanese by Combined Genotype Analysis Hypertension, May 1, 1995; 25(5): 950 - 953. [Abstract] [Full Text]
|
|
|
|
|
|
R. F. Badenhop, X. L. Wang, and D. E.L. Wilcken Angiotensin-Converting Enzyme Genotype in Children and Coronary Events in Their Grandparents Circulation, March 15, 1995; 91(6): 1655 - 1658. [Abstract] [Full Text]
|
|